Literature DB >> 15164877

Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer.

Shishir Shishodia1, Bharat B Aggarwal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15164877     DOI： 10.1007/1-4020-7847-1_8

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  40 in total

1.  TNIP1, a retinoic acid receptor corepressor and A20-binding inhibitor of NF-κB, distributes to both nuclear and cytoplasmic locations.

Authors:  Igor Gurevich; Carmen Zhang; Nidhish Francis; Brian J Aneskievich
Journal:  J Histochem Cytochem       Date:  2011-12       Impact factor: 2.479

Review 2.  Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

Authors:  Subash C Gupta; Chitra Sundaram; Simone Reuter; Bharat B Aggarwal
Journal:  Biochim Biophys Acta       Date:  2010-05-21

3.  Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer.

Authors:  Savita Bisht; Masamichi Mizuma; Georg Feldmann; Niki A Ottenhof; Seung-Mo Hong; Dipankar Pramanik; Venugopal Chenna; Collins Karikari; Rajni Sharma; Michael G Goggins; Michelle A Rudek; Rajani Ravi; Amarnath Maitra; Anirban Maitra
Journal:  Mol Cancer Ther       Date:  2010-07-20       Impact factor: 6.261

4.  Liposome-encapsulated curcumin suppresses neuroblastoma growth through nuclear factor-kappa B inhibition.

Authors:  Wayne S Orr; Jason W Denbo; Karim R Saab; Adrianne L Myers; Catherine Y Ng; Junfang Zhou; Christopher L Morton; Lawrence M Pfeffer; Andrew M Davidoff
Journal:  Surgery       Date:  2012-01-28       Impact factor: 3.982

5.  Targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistance.

Authors:  James A McCubrey; Linda S Steelman; Richard A Franklin; Steven L Abrams; William H Chappell; Ellis W T Wong; Brian D Lehmann; David M Terrian; Jorg Basecke; Franca Stivala; Massimo Libra; Camilla Evangelisti; Alberto M Martelli
Journal:  Adv Enzyme Regul       Date:  2007-03-26

6.  Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy.

Authors:  James A McCubrey; Melissa L Sokolosky; Brian D Lehmann; Jackson R Taylor; Patrick M Navolanic; William H Chappell; Stephen L Abrams; Kristin M Stadelman; Ellis W T Wong; Negin Misaghian; Stefan Horn; Jörg Bäsecke; Massimo Libra; Franca Stivala; Giovanni Ligresti; Agostino Tafuri; Michele Milella; Marek Zarzycki; Andrzej Dzugaj; Francesca Chiarini; Camilla Evangelisti; Alberto M Martelli; David M Terrian; Richard A Franklin; Linda S Steelman
Journal:  Adv Enzyme Regul       Date:  2008-02-21

7.  Bortezomib induces in HepG2 cells IkappaBalpha degradation mediated by caspase-8.

Authors:  Giuseppe Calvaruso; Michela Giuliano; Patrizia Portanova; Anna De Blasio; Renza Vento; Giovanni Tesoriere
Journal:  Mol Cell Biochem       Date:  2006-05-30       Impact factor: 3.396

8.  Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation.

Authors:  Xiaohui Zhang; Rohini Polavarapu; Hua She; Zixu Mao; Manuel Yepes
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

9.  Thymoquinone chemosensitizes colon cancer cells through inhibition of NF-κB.

Authors:  Lida Zhang; Yangqiu Bai; Yuxiu Yang
Journal:  Oncol Lett       Date:  2016-08-08       Impact factor: 2.967

Review 10.  TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion.

Authors:  Y Wu; B P Zhou
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.